Close

Clinical Trials

Catalent Partners with Humanigen to Support FDA-Approved Phase 3 Lenzilumab Study for COVID-19

Catalent, a global leader in clinical supply services, welcomed the news by Humanigen, Inc., that it has dosed the first COVID-19 patient in its...

Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received...

CTI BioPharma Initiates Phase III Pacritinib Trial in COVID-19

CTI BioPharma Corp. initiated PRE-VENT, a Phase III study evaluating pacritinib in hospitalized patients with severe COVID-19. PRE-VENT, a randomized, double-blind, placebo-controlled study, will...

COVID-19:  A catalyst for change in global clinical trials

The COVID-19 pandemic has exposed some significant frailties in the physical clinical supply chain. As governments, medical professionals and life science organisations around the...

Queen’s University leading cell therapy clinical trial to help improve outcomes in COVID-19 patients

Researchers at Queen’s University Belfast are leading a UK-wide clinical trial, offering an innovative cell therapy treatment for COVID-19 patients with acute respiratory failure. This...

Pfizer and BioNTech Aim to Start Testing Coronavirus Vaccines in Humans by Late April

Pfizer and BioNTech announced that they intend to advance multiple SARS-CoV-2 vaccine candidates into human clinical testing, with the first clinical trials potentially beginning...

A World Pharma Today exclusive with Jim Murphy, CEO, Greenphire

Who would have thought a pandemic in this modern era would cripple the world, the strongest economies would be shaken, and end up being...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read